 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Skyline Dx Partners with LabPMM to Offer Array-based AML Testing Service in Europe
June 26, 2012
Skyline Dx Partners with LabPMM to Offer Array-based AML Testing Service in Europe
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Skyline Diagnostics Preps Leukemia Test for US Launch; Gains CE-IVD Mark
March 15, 2011 / BioArray News - Clavis Pharma Taps Skyline Dx for Array-based Patient Selection in AML Drug Trial
September 6, 2011 / BioArray News - Skyline Dx, Janssen Partner on Adverse Reaction Risk Test for Multiple Myeloma Drug
July 26, 2011 / BioArray News - Q&A: INMEGEN's Alfredo Hidalgo on Using Genomics to Address Mexico's Most Pressing Health Problems
May 21, 2013 / BioArray News - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News